INTERNATIONAL PATENT: HUMANWELL PHARMACUETICAL US, INC. FILES APPLICATION FOR "SMALL MOLECULES AS KCNQ2/3 (KV7.2/3) CHANNEL ACTIVATORS AND THEIR MEDICAL USE THEREOF"

GENEVA, Oct. 1 -- HUMANWELL PHARMACUETICAL US, INC. (421 Sovereign CourtBallwin, Missouri 63011) filed a patent application (PCT/US2025/019726) for "SMALL MOLECULES AS KCNQ2/3 (KV7.2/3) CHANNEL ACTIVATORS AND THEIR MEDICAL USE THEREOF" on Mar 13, 2025. With publication no. WO/2025/198930, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DOU, Xiaozheng (c/o Humanwell Pharmaceutical US421 Sovereign CourtBallwin, Missouri 63011), KAUSHIK, Shivansh (c/o Humanwell Pharmaceutical US421 Sovereign CourtBallwin, Missouri 63011), ZH...